Table 4
Regression of rubeosis iridis and neovascular glaucoma
Eyes with >6 months’ follow up
All eyes
Rubeosis iridis regression
5/7 (71%)
5/7 (71%)
Neovascular glaucoma regression
2/3 (67%)
2/3 (67%)